Diagnosing osteoarthritis in the late stages when cartilage damage is severe can be challenging, as it is difficult to differentiate from other types of arthritis and determine the best treatment plan. Researchers have developed a new diagnostic test using two markers in the synovial fluid of patients’ joints, cartilage oligomeric matrix protein, and interleukin‐8. By assessing the levels of these markers and creating an algorithm based on their ratio, the test was able to accurately differentiate between osteoarthritis and inflammatory arthritis in human knee synovial fluid specimens. This new test aims to improve clinical decision-making and patient outcomes for osteoarthritis.
Source link